|Articles|January 29, 2021
Top questions answered on challenging HCP assays
Author(s)Cytiva
Cytiva experts answer your top questions about challenging host cell protein assays to improve risk mitigation.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
2
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
3
Optimizing Kinetics Assays to Avoid Avidity Effects
4
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
5